Study finds early referrals to hospice care can improve patients’ quality of life and reduce unnecessary emergency room admissions
Read MoreStudy Finds Biomarkers of Complications in Patients with Cancer Diagnosed with COVID-19
Study examines risks in cancer patients with COVID-19
Sustained Response Observed in MOMENTUM Trial of Patients with Myelofibrosis
At 48 weeks into the MOMENTUM study, patients taking momelotinib had symptom improvement over those taking danzol.
High Rates of Breast Cancer Recurrence after Intraoperative Radiation Therapy
Study indicates accelerated partial breast irradiation may be a preferable approach to intraoperative radiation therapy in early-stage breast cancer
Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma
Cleveland Clinic researchers aim to assess the appropriate timing and role of immunotherapies for treating advanced melanoma
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Higher-dose Stereotactic Radiotherapy Achieves Better Control for Many Aggressive Lung Tumors
Research examines the role of higher-dose radiation and fewer sessions for patients with aggressive lung cancer
Predicting Overall Survival in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
New study helps clinicians understand the role of genomic adjusted radiation dose in a patient’s overall survival.
Biosignature Tool Predicts Individual’s Benefit from Radiation Therapy Following Breast-Conserving Therapy
Biosignature improves on ability to understand recurrence risk of disease in patients with ductal carcinoma in situ.
Study Reveals Gene Expression Patterns Associated With Aggressive Pathologic Features In Prostate Cancer
Genetic testing provides clues to understanding aggressive forms of prostate cancer.
Cutaneous Squamous-cell Carcinoma Study Finds Complete Response to Immunotherapy in More than Half of Patients
Validation study demonstrates cemiplimab may be a viable alternative to surgery or may augment surgery for patients with resectable cutaneous squamous-cell carinoma.
New Selective ER Modulator Shows Promising Clinical Activity in HR-positive Metastatic Breast Cancer with ESR1 Mutation After Progression
A combination therapy is demonstrating effective results in women with ER-positive/HER2-negative metastatic breast cancer compared to treatment with abemaciclib.